Total Payments
$2,743
2024 Payments
$570.75
Companies
41
Transactions
98
Medicare Patients
1,117
Medicare Billing
$155,797
Payment Breakdown by Category
Food & Beverage$2,000 (72.9%)
Education$743.66 (27.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,000 | 90 | 72.9% |
| Education | $743.66 | 8 | 27.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $344.74 | 3 | $0 (2023) |
| Astellas Pharma US Inc | $258.65 | 9 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $162.99 | 2 | $0 (2023) |
| ABBVIE INC. | $148.96 | 2 | $0 (2024) |
| Daiichi Sankyo Inc. | $140.63 | 5 | $0 (2024) |
| Epizyme, Inc., | $115.56 | 3 | $0 (2022) |
| Incyte Corporation | $88.61 | 4 | $0 (2023) |
| Pharmacyclics LLC, an AbbVie Company | $84.61 | 2 | $0 (2022) |
| GENZYME CORPORATION | $82.41 | 4 | $0 (2023) |
| Exelixis Inc. | $80.09 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $570.75 | 22 | ABBVIE INC. ($124.76) |
| 2023 | $941.01 | 31 | Astellas Pharma US Inc ($124.51) |
| 2022 | $618.08 | 24 | Lilly USA, LLC ($107.42) |
| 2021 | $613.36 | 21 | Lilly USA, LLC ($130.69) |
All Payment Transactions
98 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/30/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Oncology | ||||||
| 09/25/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Rare Disease | ||||||
| 08/14/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $19.03 | General |
| Category: Oncology | ||||||
| 08/13/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: Oncology | ||||||
| 07/09/2024 | Genmab U.S., Inc. | Tivdak (Drug) | Food and Beverage | In-kind items and services | $33.04 | General |
| Category: Oncology | ||||||
| 06/12/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: ONCOLOGY | ||||||
| 06/04/2024 | Genentech USA, Inc. | Polivy (Biological) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: BioOncology | ||||||
| 05/25/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Oncology | ||||||
| 05/18/2024 | SERVIER PHARMACEUTICALS LLC | Oncaspar (Drug), IDHIFA, Tibsovo | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Oncology | ||||||
| 05/15/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 05/07/2024 | Astellas Pharma US Inc | Xospata (Drug) | Food and Beverage | In-kind items and services | $27.96 | General |
| Category: Oncology | ||||||
| 04/23/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Oncology | ||||||
| 04/16/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $17.12 | General |
| 04/02/2024 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $29.25 | General |
| Category: Oncology | ||||||
| 03/19/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Oncology | ||||||
| 03/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $124.76 | General |
| Category: NEUROSCIENCE | ||||||
| 03/05/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 02/27/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.76 | General |
| 02/21/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: Oncology | ||||||
| 02/13/2024 | Genentech USA, Inc. | Alecensa (Biological), Gazyva, Lunsumio | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: BioOncology | ||||||
| 02/06/2024 | ARRAY BIOPHARMA INC | XALKORI (Drug), LORBRENA, BRAFTOVI | Food and Beverage | In-kind items and services | $25.57 | General |
| Category: ONCOLOGY | ||||||
| 01/17/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $28.79 | General |
| Category: ONCOLOGY | ||||||
| 12/18/2023 | SANOFI-AVENTIS U.S. LLC | JEVTANA (Drug) | Education | In-kind items and services | $95.00 | General |
| Category: Oncology | ||||||
| 12/04/2023 | Apellis Pharmaceuticals, Inc. | Empaveli (Drug) | Food and Beverage | Cash or cash equivalent | $28.42 | General |
| Category: Hematology | ||||||
| 11/28/2023 | Novartis Pharmaceuticals Corporation | KISQALI (Drug), PIQRAY | Food and Beverage | In-kind items and services | $28.22 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 215 | 631 | $137,449 | $37,687 |
| 2022 | 3 | 236 | 713 | $203,084 | $42,313 |
| 2021 | 3 | 312 | 888 | $203,806 | $54,327 |
| 2020 | 8 | 354 | 456 | $92,242 | $21,469 |
Total Patients
1,117
Total Services
2,688
Medicare Billing
$155,797
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 183 | 581 | $130,299 | $35,150 | 27.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 21 | 38 | $4,750 | $1,989 | 41.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 12 | $2,400 | $548.06 | 22.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 194 | 670 | $197,684 | $41,017 | 20.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 11 | $2,200 | $689.02 | 31.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 31 | 32 | $3,200 | $606.83 | 19.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 235 | 809 | $190,417 | $51,539 | 27.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 11 | 11 | $6,589 | $1,484 | 22.5% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 66 | 68 | $6,800 | $1,304 | 19.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 98 | 198 | $47,002 | $10,643 | 22.6% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 39 | 39 | $11,700 | $2,854 | 24.4% |
| 99201 | New patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 71 | 71 | $9,230 | $2,477 | 26.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 48 | 50 | $9,890 | $2,435 | 24.6% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 34 | 34 | $6,685 | $1,714 | 25.6% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 29 | 29 | $5,075 | $926.81 | 18.3% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 20 | 20 | $2,060 | $366.26 | 17.8% |
| 81002 | Urinalysis, manual test | Office | 2020 | 15 | 15 | $600.00 | $52.20 | 8.7% |
About Murtaza Singaporewala, PA
Murtaza Singaporewala, PA is a Medical healthcare provider based in Albany, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2005. The National Provider Identifier (NPI) number assigned to this provider is 1427055698.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Murtaza Singaporewala, PA has received a total of $2,743 in payments from pharmaceutical and medical device companies, with $570.75 received in 2024. These payments were reported across 98 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($2,000).
As a Medicare-enrolled provider, Singaporewala has provided services to 1,117 Medicare beneficiaries, totaling 2,688 services with total Medicare billing of $155,797. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical
- Location Albany, NY
- Active Since 07/03/2005
- Last Updated 10/03/2016
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1427055698
Products in Payments
- JEVTANA (Drug) $183.16
- VERZENIO (Drug) $130.69
- QULIPTA (Drug) $124.76
- TAZVERIK (Drug) $115.56
- IMBRUVICA (Drug) $105.20
- Enhertu (Drug) $88.11
- LIBTAYO (Biological) $78.36
- CABOMETYX (Drug) $63.39
- SARCLISA (Biological) $62.24
- XALKORI (Drug) $58.32
- Empaveli (Drug) $56.66
- OPDIVO (Biological) $53.34
- ENHERTU (Drug) $52.52
- BRUKINSA (Drug) $47.81
- NERLYNX (Drug) $47.44
- Xospata (Drug) $46.96
- Padcev (Drug) $43.81
- SCEMBLIX (Drug) $42.58
- MONOFERRIC (Drug) $42.48
- JAKAFI (Drug) $41.05
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Doctors in Albany
Ms. Rebecca Ellwood, Pa-C, PA-C
Medical — Payments: $403,764
Medical $403,764
Brianna Samson, Pa-C, PA-C
Medical — Payments: $4,331
Medical $4,331
Peter Schuman, Rpa-C, RPA-C
Medical — Payments: $2,701
Medical $2,701
John Dennis, Pa-C, PA-C
Medical — Payments: $2,518
Medical $2,518
Erin Bethon, Pa, PA
Medical — Payments: $2,451
Medical $2,451
Jenna Locaputo, Pa-C, PA-C
Medical — Payments: $2,373
Medical $2,373